BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 330944)

  • 1. The infectivity of drug resistant cases.
    Desai AC; Apte SN; Bhide MB
    Lepr India; 1977 Jan; 49(1):54-8. PubMed ID: 330944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds.
    Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN
    Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
    Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
    Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
    Dhople AM
    Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse foot pad growth of M. leprae in relation to bacteriological index.
    Bhatia VN; Balakrishnan S; Venkataramaniah HN; Harikrishnan S
    Lepr India; 1983 Apr; 55(2):247-51. PubMed ID: 6355651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of desoxy fructo serotonin (DFS) on the multiplication of M. leprae in mouse foot-pad.
    Balakrishnan S; Mester L; Venkataramanaiah HN; Bhatia VN
    Lepr India; 1982 Jan; 54(1):56-8. PubMed ID: 7047899
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
    Waters MF; Pearson JM; Rees RJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
    [No Abstract]   [Full Text] [Related]  

  • 9. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes.
    Pattyn SR
    Acta Leprol; 1983; 1(1):29-32. PubMed ID: 6401137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
    Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
    Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone resistance in Mycobacterium leprae.
    Gillis TP; Williams DL
    Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary dapsone resistance in Cebu, The Philippines; cause for concern.
    dela Cruz E; Cellona RV; Balagon MV; Villahermosa LG; Fajardo TT; Abalos RM; Tan EV; Walsh GP
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):253-6. PubMed ID: 8862258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
    Gupta UD; Katoch K; Katoch VM
    Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 16. Does dapsone resistance really matter in the MDT era?
    Ji B
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of drug resistance in Dharmapuri and A. Pallipatti areas of Tamil Nadu.
    Sreevatsa ; Ramu G; Desikan KV
    Indian J Lepr; 1985; 57(2):376-82. PubMed ID: 3908580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.